Figure 4.
The clinical-pathological feature of NR5A2 in HNSCC. (A, B) The disease-free survival (A) and overall survival (B) of NR5A2 in HNSCC analyzed by the GEPIA web tool, P values as indicated. (C) The mRNA expression level of NR5A2 analyzed by the GEPIA web tool, n.s., not significant. (D, E) The protein levels of NR5A2 from the tissue microarray (n = 10 normal tissues, n = 29 HNSCC tumor tissues) were determined by IHC analysis, n.s., not significant.